Real World Evidence (RWE) from Clinical Development to Patient Access

This white paper is part of DIA’s White Paper Library
Value based payment (VBP) has emerged as an effective strategy to promote the quality and value of medical products, devices or health care services. The goal of any VBP program is to shift from pure volume-based payment, to payments that are related to the desired health outcomes. The transition to VBP has underscored the importance of Real World Evidence (RWE) as a radical approach to bridge the evidence gap for medical products and devices.
Download Now!

For more information on publishing your White Paper with DIA, including schedule and pricing, please contact Heej Ko at [email protected].